QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today announced the expansion of its U.S.-based Phase I clinical…
QPS Neuro and Pronexus Analytical announced formation of a joint partnership aiming to build their respective areas of expertise on unified experimental platforms and…
New capacity will support large-scale, Phase III drug trials QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support…
Study to be conducted at QPS facilities in Groningen, the Netherlands Kancera AB, a pharmaceutical development company currently focused on the treatment of cancer…
New, five-year facility offers greater financial flexibility QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and…
The first-in-human study with ACT017 will be conducted at QPS facilities in Groningen, the Netherlands. Acticor Biotech, a biotechnology company focused on the treatment…
Complementary world-class capabilities prime for accelerating cardiovascular drug development QPS Holdings LLC and G-CURE BV announce today that they have signed an agreement to…
Nomination a by-product of employee, client, vendor and community support Dr. Benjamin Chien, CEO of QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research…
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification SCIEX, a global leader in life science analytical technologies, and QPS Holdings, LLC…
Agreement solidifies cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and hepatic stellate cells Hepatic Biosciences,…